A striking elevation of CA19-9 after preoperative therapy negates prognostic benefit from radical surgery in resectable and borderline resectable pancreatic cancer
Hirofumi Akita, Yosuke Mukai, Masahiko Kubo, Hidenori Takahashi, Shinichiro Hasegawa, Masatoshi Kitakaze, Norihiro Matsuura, Yasunori Masuike, Takahito Sugase, Naoki Shinno, Takashi Kanemura, Hisashi Hara, Toshinori Sueda, Junichi Nishimura, Masayoshi Yasui, Takeshi Omori, Hiroshi Miyata, Masayuki Ohue, Hiroshi Wada
Topics & Concepts
MedicineRadical surgeryPancreatic cancerNeoadjuvant therapySurgeryCancerQuality of life (healthcare)Internal medicineBreast cancerNursingPancreatic and Hepatic Oncology ResearchCancer Research and TreatmentsPancreatitis Pathology and Treatment